Immunovia AB (FRA:1YR)
€ 0.0338 0.0013 (4%) Market Cap: 8.99 Mil Enterprise Value: 6.59 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 42/100

Q4 2022 Immunovia AB (publ) Earnings Call Transcript

Feb 23, 2023 / 10:00AM GMT
Release Date Price: €0.372203 (-0.15%)
Operator

Ladies and gentlemen, welcome to the Immunovia Q4 Interim Report 2022 Conference Call. I'm Sasha, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it is my pleasure to hand over to Karin Almqvist, CFO.

Karin Almqvist Liwendahl;publ;CFO;Philipp Mathieu;publ
Immunovia AB;Immunovia AB

()-

Good morning all, and most welcome to this conference call following our fourth quarter results. Present here is Philipp Mathieu, CEO; and myself, Karin Almqvist, and I am the CFO of the company. Before we start, there are, as usual, some practical aspects. This presentation will be followed by a Q&A session, and our operator will guide us through on how to pose the questions.

After we have closed today's call, you will find the presentation and recording on our website. And with that, I would like to hand over to our CEO, Philipp, please.

- ()

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot